Abstract
Objective: To evaluate the comparative efficacy and safety of Janus kinase (JAK) inhibitors and biological disease-modifying antirheumatic drugs (bDMA......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
